Ever After Foods and Roslin Technologies Achieve Major Leap in Cultivated Meat ProductivityGlobeNewsWire · Oct 13, 2026
Pluri (PLUR) to Post Earnings on WednesdayDefense World · Sep 16, 2026
Pluri Announces Pricing of $3.3 Million Registered Direct Offering and Concurrent Private Placement with a Single Healthcare Focused Institutional InvestorGlobeNewsWire · Aug 27, 2026
Plurilock Security Inc. (PLUR:CA) Discusses Corporate Update and Growth Strategy in Defense Contracting Portfolio TranscriptSeeking Alpha · Aug 20, 2026
Pluri's Ever After Foods Expands Cultivated-Protein Platform Through Fishway Acquisition and Strategic InvestmentGlobeNewsWire · Aug 17, 2026
Pluri Advances Commercial Expansion Through Its Subsidiary Cellav, Completing Regulatory Registration in the UKGlobeNewsWire · Jul 28, 2026Pluri Inc., a biotechnology company established in 2001 and headquartered in Haifa, Israel, specializes in developing innovative placenta-derived cell therapies. Its core mission is to tackle a range of inflammatory conditions, muscle injuries, and hematological disorders. The company's therapeutic pipeline centers on placental expanded (PLX) cell technology.
| Date | Est. | Actual | |
|---|---|---|---|
| Sep 10, 2026 | -$0.66 | -$0.54 | Beat |
| May 14, 2026 | -$0.66 | -$0.55 | Beat |
| Feb 12, 2026 | -$0.65 | -$0.71 | Miss |
| Nov 12, 2025 | -$0.74 | -$0.65 | Beat |
| Sep 17, 2025 | -$0.65 | -$2.62 | Miss |
| May 13, 2025 | -$0.73 | -$0.94 | Miss |